Silihan lan utang jangka dawa perusahaan: NanoVibronix Inc. (NAOV)

NanoVibronix, Inc. (NAOV) is expanding its B2B reach by promoting UroShield ultrasonic systems, while partner production capacities are operating efficiently following the update of calibration systems. The stock chart on GURU.Markets serves as an indicator, where long-term debt stands at 0.00. The issuer's financial stability is increasing due to sales diversification across the hospital and retail sectors, ensuring moderate revenue growth.

Long-term debt measures the total liabilities with a maturity of more than one year, determining the issuer's financial stability. By analyzing the long-term liabilities of a company, an investor assesses the business's ability to service loans amid changing market conditions. The current value of 0.00 reflects the volume of borrowed capital directed toward strategic development. For NanoVibronix, Inc. (NAOV), this is critical when scaling UroShield systems through clinics. This metric demonstrates the balance between the aggressive implementation of medtech and liquidity risks.